Background: Early definitive treatment (cholecystectomy or endoscopic sphincterotomy in the same admission or within 2 weeks after discharge) of gallstone disease after a biliary attack of acute pancreatitis is standard of care. This study investigated whether compliance with early definitive treatment for acute gallstone pancreatitis can be used as a care quality indicator for the condition. 
Introduction
Acute pancreatitis is one of the most common intra-abdominal emergency conditions and its incidence is increasing 1 . This has contributed to an additional 54 per cent rise in the number of bed-days used to treat acute pancreatitis over the same period 2 . The incidence varies with predominating aetiologies, the most common being gallstones, reported in 35-40 per cent 3, 4 . Despite advances in treatment, acute pancreatitis is still associated with considerable morbidity and mortality 5, 6 .
Based on available evidence and recommended guidelines 7 , patients with mild gallstone pancreatitis should undergo definitive treatment of their gallstones, namely a cholecystectomy or, if unfit for surgery, an endoscopic sphincterotomy during the same hospital admission or within 2 weeks of discharge. Adherence to these recommendations improves patient outcomes, with a reduction in overall hospital stay and further episodes of acute pancreatitis 8 -10 . Previous studies 8, 10 have shown variable adherence to the guidelines, but the variation that may exist between trusts of varying size and structure, and how this may impact patient outcomes, have not been investigated at a national level. Likewise, there is increasing evidence of variation in the quality of care provided to patients in hospitals and a resultant increasing emphasis on empirical monitoring to help reduce it 11 -13 .
The most common measures of the quality of surgical care are outcome measures such as mortality, surgical complication rates and 30-day readmission rates 14 . Although clearly important by representing what ultimately happens to the patient, there are limitations with such measures, including a lack of sensitivity, their multifactorial nature (making it difficult for individual clinicians or teams to know what to alter) and the need for standardized definitions 15 . Process measures, on the other hand, are more sensitive to change, more actionable by clinical teams, and may be viewed as the 'closest approximation of actual health care offered' 16 . Accordingly, the development of new process indicators may enable the design of new strategies to complement outcome measures, for improved monitoring and quality of care 17 .
Compliance with existing guidelines (and hence the proportion of patients receiving early definitive treatment) across England is variable 10 . The aim of this study was to examine variation in patients receiving early definitive treatment of gallstones following an episode of acute gallstone pancreatitis between trusts and hospitals, and to determine its validity as an indicator of quality of care for acute biliary pancreatitis.
Methods
The study used the Hospital Episode Statistics (HES) database, an administrative database of all admissions to English National Health Service hospitals. Each admission episode record consists of over 40 information fields, including patient details, diagnoses coded according to the ICD-10, and the use of OPCS-4 classification of surgical operations and procedures codes. Types of admission and discharge details are also recorded. A unique patient identifier within HES allows each patient's hospital experience to be tracked. Using this identifier, admission and discharge details were identified and patients who underwent interhospital transfer during their initial hospital stay were included.
Index admission for acute gallstone pancreatitis
A patient was defined as presenting with their first episode of acute gallstone pancreatitis if no previous related diagnosis of pancreatitis or related operation was evident in the preceding year's HES data for that patient. An episode of acute gallstone pancreatitis required a diagnosis of acute pancreatitis (K85X) plus a diagnosis of acute gallbladder pathology (cholelithasis (K80*), cholecystitis (K81*), cholangitis (K830) or obstruction of the Patients were excluded if they had a previous diagnosis of acute pancreatitis or operative fields with codes for cholecystectomy or endoscopic sphincterotomy in the 12 months preceding the identified emergency admission with acute gallstone pancreatitis (termed the index admission). Cholecystectomy is contraindicated in severe acute pancreatitis. Thus, patients thought to have severe pancreatitis were also excluded from the study. As pancreatitis severity is not coded in HES, surrogate markers were used: death or a critical care admission during the index admission. Death in hospital was identified using the discharge method field in HES, and a critical care admission was identified using the treatment specialty field in HES. Patient records from fiscal years 2007 and 2011 were also used to extract preadmission co-morbidity data and 1-year follow-up data respectively. Using data beyond 2007 allowed 1 year to give the opportunity for the new revised 2005 guidelines to be incorporated into hospital practice. Values in parentheses are percentages unless indicated otherwise; *values are median (i.q.r.). †Data missing for four patients in early treatment group and 35 in late/no treatment group.
Definition of timing of treatment
Early definitive treatment was defined as treatment in accordance with the 2005 British Society of Gastroenterology guidelines 7 , namely cholecystectomy or endoscopic sphincterotomy during the same hospital admission (index admission) or within 2 weeks of discharge.
Other study variables
Specific factors with potential associations with surgical risk and more widely applied determinants of health were identified for all patients: age at time of index admission, sex, ethnicity and socioeconomic status, as measured by the English Indices of Deprivation 2004 ranking 18 of the super output areas and further grouped according to quintiles. Co-morbidities were assessed using the Royal College of Surgeons Charlson co-morbidity score 19 , by examining HES records during the year before the index admission. Variation in structural aspects at trust level were considered and identified a priori as potential confounders. Two variables were constructed. The first was specialist hepatopancreaticobiliary (HPB) centre status, as major HPB surgery has now been centralized into specialist centres in the UK. These were defined as trusts with one or more hospitals performing at least ten major liver or pancreatic resections (excision of head of pancreas (J56) or partial excision of liver (J02)) per year over the 3 years. The second was the trust mean annual cholecystectomy volume, providing a proxy measure of benign general surgical experience and grouped according to tertiles.
Outcome variables
Readmissions at 30 days, 90 days and cumulative incidence in the first year were defined as emergency admissions diagnosed with acute pancreatitis (K85x) or gallbladderassociated diagnoses (K80*, K81*, K830, K831), compared with those not requiring a readmission. For patients who died during a gallstone pancreatitis-related readmission, mortality rates are described based on hospital mortality. Fig. 3 Funnel plot demonstrating the proportion of patients undergoing early definitive treatment in each trust compared with the national rate and its inner and outer limits extent of variation in the proportion of patients receiving early definitive treatment across trusts. The funnel plot was generated using two-sided control limits defining differences corresponding to two standard deviations (inner limits) and three standard deviations (outer limits) from the national average. Low-volume trusts (fewer than 15 patients admitted for gallstone pancreatitis) were excluded from the funnel plot. Scatter plots with associated regression lines and correlation coefficients are presented to illustrate the association between the proportion receiving early definitive treatment and key patient outcomes at trust level.
Statistical analysis
Before the regression analysis, multiple imputation by chained equations 20 was used to deal with any missing values of case-mix factors (age, deprivation, ethnicity, and trust cholecystectomy volume). Missing values were Values in parentheses are *percentages and †95 per cent confidence intervals. ‡All emergency readmissions. §Adjusted for age, sex, ethnicity, socioeconomic status, Charlson co-morbidity score and structural factors; all P < 0⋅001.
replaced with ten sets of plausible values. Rubin's rules were used to combine estimates and obtain overall adjusted RRs 21 .
Results
In the study period, 21 850 patients were identified as having had an emergency admission for acute gallstone pancreatitis. A total of 2340 patients were excluded from the study, leaving 19 510 patients for analysis; 6733 received early definitive treatment (either a cholecystectomy or an endoscopic sphincterotomy) within 2 weeks of discharge, and 12 777 either had no treatment or treatment after 2 weeks (late/no definitive treatment) (Fig. 1) . The characteristics of patients in the two groups are shown in Table 1 .
Treatment patterns
The cumulative pattern of patients receiving definitive treatment in the index admission and during the following year is shown in Fig. 2 . Some 5553 patients (28⋅5 per cent) had early definitive treatment during the index admission; 2168 had a cholecystectomy, 3111 an endoscopic sphincterotomy, and 274 had both procedures. Thus, 13 957 patients were discharged without any treatment. In the first 2 weeks after discharge, a further 1180 patients (6⋅0 per cent) went on to have early definitive treatment; 386 had endoscopic sphincterotomy alone, 794 had cholecystectomy alone, and none had both procedures. By the end of the 1-year follow-up, 14 474 of the 19 510 patients (74⋅2 per cent) had received definitive treatment; 9249 (47⋅4 per cent) had a cholecystectomy alone, 2572 (13⋅2 per cent) an endoscopic sphincterotomy alone, and 2653 (13⋅6 per cent) had both procedures. Some 5036 patients (25⋅8 per cent) had received no definitive treatment by the end of the follow-up period.
Variation between trusts in early definitive treatment
A total of 151 trusts were identified that treated patients with acute gallstone pancreatitis across all 3 years. To 4 Kaplan-Meier graph demonstrating the cumulative emergency readmission rate over 1 year. Numbers at risk after discharge are not included as it was not possible to exclude out-of-hospital deaths because this information was not available minimize errors arising from miscoding, five of these trusts were excluded from the analysis as they had fewer than 15 admissions over the study interval, leaving 146 trusts that were included.
The proportions of patients receiving early definitive treatment varied substantially between these 146 trusts, ranging from 9⋅4 to 84⋅7 (mean 34⋅7) per cent. In 21 hospital trusts (14⋅4 per cent), fewer than one in five patients presenting with acute gallstone pancreatitis received definitive treatment within 2 weeks of discharge. Fig. 3 illustrates the variation in early definitive treatment by trust using a funnel plot with the assumption that the target rate is the overall mean. Table 2 summarizes the association between early definitive treatment and key patient outcomes. Table S1 (supporting information) shows all four multivariable models used to assess the associations between early definitive treatment and readmission rates. 
Impact of early definitive treatment on patient outcome

Emergency readmissions
In the 1-year follow-up interval, 4661 patients (23⋅9 per cent) had one or more emergency readmissions for gallstone pancreatitis related complications. Of these, 2692 (57⋅8 per cent) were readmissions for acute pancreatitis; 911 (33⋅8 per cent) were within the first 2 weeks after discharge, with the remaining 1781 (66⋅2 per cent) occurring after the point at which the patient should have received definitive treatment. Those receiving early definitive treatment had a lower estimated risk of readmission except for a brief period at the very start of the follow-up after discharge, as shown in the Kaplan-Meier plot (Fig. 4) . Early definitive treatment was associated with a 39 per cent reduction in readmission rate (adjusted RR 0⋅61, 95 per cent c.i. 0⋅58 to 0⋅65). The risk was further reduced for acute pancreatitis readmissions to 54 per cent (adjusted RR 0⋅46, 0⋅42 to 0⋅51).
Readmission rate was highest in the first 30 days for both groups. Multivariable analysis showed that patients receiving early definitive treatment were 15 per cent less likely to be readmitted as an emergency within 30 days (adjusted RR 0⋅85, 95 per cent c.i. 0⋅78 to 0⋅92), as well as 34 per cent less likely to have an emergency readmission by 90 days (adjusted RR 0⋅66, 0⋅62 to 0⋅71). Of the 4661 patients having an emergency readmission, 162 (3⋅5 per cent) died in the same admission; 29 patients received early definitive treatment and the remaining 133 had late or no definitive treatment. Fig. 5 shows the relationship between early definitive treatment rates and readmission rates at trust level. All show a statistically significant (P < 0⋅001) negative association, with correlation coefficients of −0⋅44, −0⋅53, −0⋅57 and −0⋅56 for 30-day, 90-day, 1-year and acute pancreatitis readmission rates respectively.
Outcome rates at trust level
Outcomes related to structural aspects of trusts
Patients were 36 per cent more likely to receive early definitive treatment if they were treated within a trust with a specialist HPB centre (adjusted RR 1⋅36, 95 per cent c.i. 1⋅29 to 1⋅42). Trusts with a mean cholecystectomy volume in the second tertile were more likely to treat patients within 2 weeks compared with those in the lowest tertile (adjusted RR 1⋅12, 1⋅06 to 1⋅18) ( Table S1 , supporting information).
Discussion
The results of this study support the use of early definitive treatment of gallstones following an episode of acute pancreatitis. After adjusting for case mix, early definitive treatment was independently associated with improvements in patient outcomes (measured as hospital readmission rates). The study also indicates that the rate of early definitive treatment for gallstones following an attack of acute gallstone pancreatitis is a valid quality indicator of care.
A high rate of early definitive treatment was associated with improvement in all patient outcomes considered in this study. Rates of readmission for acute pancreatitis were improved in patients who received early definitive treatment, which substantiates results reported by related studies 22, 23 . Readmissions are of particular importance in acute gallstone pancreatitis as the primary aim of treatment is to prevent further attacks of acute pancreatitis and the resulting morbidity and mortality. The separate acute pancreatitis readmission rate was useful to demonstrate the reduction in the burden of readmissions for this specific reason. The reduction in readmission rates also has implications for potential cost savings as well as reducing patient morbidity. Several studies 13, 24 have found that earlier treatment can be cost-neutral.
Despite the strong evidence for early definitive treatment, this study has shown wide variation between trusts in their adherence to guidelines. Previous studies documented early definitive treatment rates ranging from 33 per cent 25 to 89⋅6 per cent 26 , with one study 27 finding that only 44⋅7 per cent of patients had received definitive treatment by 8 months. Concerns have been raised in several studies regarding the feasibility of early definitive treatment in smaller local hospitals in particular, owing to issues such as limited emergency operating capacity, competition from other specialties and lack of access to the required specialist expertise such as endoscopic retrograde cholangiopancreatography and surgeons trained in acute gallbladder surgery 28, 29 . Consistent with this, patients were more likely to receive early definitive treatment if they were treated in a regional specialist hepatobiliary centre or a hospital with a high annual cholecystectomy volume. On the other hand, this study demonstrates that by implementing best care (early definitive treatment) hospitals can improve patient outcomes independent of their size or specialty status. Although only data from England were examined, the findings can probably be extrapolated to other Western countries.
Early definitive treatment is a valid care quality indicator for acute gallstone pancreatitis. Quality indicators need to satisfy several criteria: to be feasible to measure, modifiable and sensitive to change, and clinically important with a robust evidence base linking the indicator to improved patient outcomes 17, 30 . The present authors have shown that the rate of early definitive treatment is easily measurable using an existing administrative data set. Although HES is specific for England, other countries have similar data sets (often, like HES, originally designed for the purpose of reimbursement) in which this indicator would be equally measurable. Further, the observed variation implies (although does not directly indicate in itself) that the rate is modifiable. An advantage of process over outcome indicators is that they act not only as a measure, but also as a strategy for improvement in themselves, by pointing directly to what services need to do to improve care. This is in contrast to outcome indicators, which are often less sensitive and multifactorial, meaning that a trust with poor performance may well not know what is needed for improvement.
Several limitations of study design, data and analysis need to be considered. First, distinguishing patients with severe pancreatitis from milder cases was difficult as calculating severity requires detailed clinical information not included in the HES database. Severe pancreatitis has a higher morbidity and mortality, and requires different management strategies to milder cases. To try to mitigate for this, patients who did not survive to initial discharge or who were admitted to critical care in their index admission were excluded. Another limitation is that it was not possible to estimate the association between early definitive treatment and mortality because Office for National Statistics mortality data were unavailable.
A large proportion of patients, 5036 (25⋅8 per cent), did not receive definitive treatment within 1 year. The authors are unable to determine whether conservative treatment was appropriate or not in these patients. Half of these patients had a Charlson co-morbidity score of zero, indicating low surgical risk and providing some evidence against the argument that these patients were too unfit for surgery. Further studies are required to better establish what factors are influencing a non-surgical management approach. Finally, all studies involving a large database are dependent on the quality of the data contained within it. The reliability and validity of HES data have been studied in relation to both missing data and coding errors. The coding accuracy of HES data is 91 per cent 31 , although this varies depending on the field studied. Importantly for this study, fields relating to admission and discharge have improved substantially, from 73⋅8 to 96⋅0 per cent 31 . However, the possibility that the present results may have been influenced by coding errors cannot be excluded.
